Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on ...

For Vertex, the consensus sales estimate for the current quarter of $2.68 billion indicates a year-over-year change of +7.8%. For the current and next fiscal years, $10.74 billion and $11.8 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

LONDON, August 07, 2024--Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT) patients to ...

Shares of biotech company Vertex Pharmaceuticals (VRTX) are down in today’s trading despite the company upping its revenue ...

The best time to visit Aspen is from December to February. The town sparkles when it's buried under fresh powder, and its slopes are ready to be taken by storm. Keep in mind that this is the most ...

By Matt Richtel Mr. Brooks has resigned from a paid post at the Aspen Institute, a think tank, and will be involved as a volunteer with a group he founded at Aspen, the paper said. By Marc Tracy ...

View Vertex Pharmaceuticals Incorporated (VRTX) current and estimated P/E ratio data provided by Seeking Alpha.

1 Day VRTX -2.72% DJIA 0.09% S&P 500 -0.19% Health Care/Life Sciences 0.99% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

However, he sees opportunities outside of the GLP-1 landscape, pointing specifically to Regeneron (REGN) and Vertex (VRTX) as prime examples. Vertex, a leader in cystic fibrosis research ...